Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Massachusetts, Worcester
About this trial
This Study will comprehensively evaluate a multi-component suicide prevention technology (Jaspr Health) that facilitates delivery of suicided-related evidence-based practices (EBPs) while replacing wasted waiting time with productive time in the Emergency Departments (EDs). The EBPs satisfy several key performance elements for systems adopting Zero Suicide.
A Complementary Randomized Controlled Trial and Real-World Study for Efficacy, Effectiveness, and Implementation Study Design (CREID) will be used
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Positive for suicide risk on the Patient Safety Screener in the ED (active suicidal ideation int the past 2 weeks, or suicidal attempt in the past 6 months)
Cognitively and emotionally capable of consent and engaging in Jaspr app.
Reads English at 6th grade level.
Reliable telephone access.
Disqualifiers
Prisoners or in state custody
Adults unable to consent
Patient <18 yeas
Enrolled subjects during the 12 month follow-up period
Trial design
Design model
Parallel
Treatments tested in this trial
Jaspr App + JAH
DeviceWith assistance form a research coordinator, the subject will complete self-administered suicide risk assessment on the tablet via Jaspr app, then the subject will engage with suicide-related coping skills and resources that the app provides. Subject will continue to have access to the coping skills and videos via a mobile app after discharge.
ETAU
BehavioralUsual care for suicidal patients at UMass Memorial ED that may include Behavioral health evaluation by a trained clinician. Environmental safety precautions. Personalized safety upon discharge
Treatment groups
670 Participants
are divided into 2 treatment groupsGroup A: Enhanced treatment as usual (ETAU) aloneActive comparator 1 intervention
Group B: Jaspr intervention with enhanced treatment as usual (ETAU)Experimental treatment 2 interventions
Trial outcomes
Primary outcomes
1
Suicide composite, binary
Death by suicide OR suicide-related acute care utilization within 12 months after enrollment
Time frame
12 months after enrollmentSecondary outcomes
1
Suicidal attempt
Suicidal attempt measured by the Columbia-Suicide Severity Rating Scale (CSSRS), Suicide attempt present Y/N
Time frame
12 months after enrollment2
Suicidal behavior
Suicidal behavior measured by the Columbia-Suicide Severity Rating Scale (CSSRS), including any preparatory, aborted, interrupted, and actual suicidal attempts. Suicidal Behavior present Y/N
Time frame
12 months after enrollment3
Suicidal ideation severity
Suicidal ideation severity measured by the Columbia-Suicide Severity Rating Scale (CSSRS). Suicidal Ideation (Highest Level Endorsed 1-5. 1= least severe and 5= highest severity)
Time frame
12 months after enrollmentOther outcomes
1
Evidence-Based Practice (EBP) delivery
Number of patients receiving evidence based care, including evidence based suicide risk assessment, safety planning, lethal means safety counseling, cognitive behavioral therapy (CBT) coping skills training, suicide education materials, and behavioral health referral resources. Higher count = more EBPs delivered
Time frame
During index visit= Day 12
Patient target engagement, perceived social support
Perceived social support (attachment/affiliation) measured by Interpersonal Needs Questionnaire (INQ-15), Likert-type scale, higher scores = stronger social support
Time frame
12 months after enrollment3
Patient target engagement, suicide-related coping
Suicide-related coping (behavioral inhibition) measured by Suicide-Related Coping Scale (SRCS), Likert-type scale, higher scores = better ability to cope with suicidal thoughts
Time frame
12 months after enrollment4
Patient target engagement, behavioral activation
Behavioral activation (effort) measured by Behavioral Activation Scale (BAS) - Drive sub scale, Likert-type scale, higher scores = greater behavioral activation
Time frame
12 months after enrollmentSponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Massachusetts, Worcester
Lead sponsor
Ohio State University
Collaborator
Evidence-Based Practice Institute, Seattle, WA
Collaborator
Worcester Polytechnic Institute
Collaborator
National Institute of Mental Health (NIMH)
Collaborator
University of Colorado, Denver
Collaborator
Source ClinicalTrials.gov